Modera Wealth Management LLC Has $2.59 Million Stock Position in Align Technology, Inc. $ALGN

Modera Wealth Management LLC reduced its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 11.0% during the 2nd quarter, HoldingsChannel reports. The firm owned 13,653 shares of the medical equipment provider’s stock after selling 1,694 shares during the quarter. Modera Wealth Management LLC’s holdings in Align Technology were worth $2,585,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the business. Teacher Retirement System of Texas bought a new position in Align Technology during the first quarter worth $1,647,000. U.S. Capital Wealth Advisors LLC raised its holdings in Align Technology by 39.2% in the 1st quarter. U.S. Capital Wealth Advisors LLC now owns 2,079 shares of the medical equipment provider’s stock valued at $330,000 after acquiring an additional 586 shares in the last quarter. Crossmark Global Holdings Inc. boosted its stake in Align Technology by 10.0% during the first quarter. Crossmark Global Holdings Inc. now owns 2,474 shares of the medical equipment provider’s stock worth $393,000 after buying an additional 225 shares in the last quarter. LBP AM SA increased its stake in Align Technology by 9.3% in the first quarter. LBP AM SA now owns 7,088 shares of the medical equipment provider’s stock valued at $1,126,000 after acquiring an additional 602 shares during the period. Finally, Allworth Financial LP lifted its position in shares of Align Technology by 5.8% during the 1st quarter. Allworth Financial LP now owns 2,557 shares of the medical equipment provider’s stock worth $406,000 after buying an additional 141 shares during the period. 88.43% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on ALGN shares. Piper Sandler reiterated an “overweight” rating and issued a $200.00 price objective (up previously from $190.00) on shares of Align Technology in a research report on Thursday, October 30th. UBS Group reduced their target price on Align Technology from $160.00 to $155.00 and set a “neutral” rating on the stock in a report on Thursday, October 16th. Weiss Ratings downgraded Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, October 8th. Wells Fargo & Company reduced their target price on shares of Align Technology from $199.00 to $181.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. Finally, Morgan Stanley lifted their price objective on shares of Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Align Technology currently has a consensus rating of “Hold” and a consensus price target of $175.45.

Align Technology Trading Up 0.8%

NASDAQ:ALGN opened at $134.84 on Friday. The stock has a 50 day simple moving average of $132.60 and a 200 day simple moving average of $160.65. Align Technology, Inc. has a 1-year low of $122.00 and a 1-year high of $246.19. The stock has a market cap of $9.77 billion, a P/E ratio of 26.13, a PEG ratio of 1.49 and a beta of 1.84.

Align Technology (NASDAQ:ALGN) last released its earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.23. The firm had revenue of $995.69 million during the quarter, compared to analysts’ expectations of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The company’s quarterly revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the company earned $2.35 earnings per share. Align Technology has set its Q4 2025 guidance at EPS. As a group, sell-side analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology declared that its Board of Directors has initiated a stock repurchase program on Tuesday, August 5th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to purchase up to 2% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.